MSB 7.63% $1.34 mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-148

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 904 Posts.
    lightbulb Created with Sketch. 174
    Mesoblast (MSB) has no revenue, makes no profits, burns a lot of money and produces nothing. It's not the kind of stock one would like to hold indefinitely, especially a lot of it. But there are times when it's an obvious buy... and sell, of course. Sold!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.